Strahan v. Massachusetts Executive Office of Energy and Environmental Affairs

District Court, D. Massachusetts·Decided June 3, 2021·No. 1:19-cv-10639·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS RICHARD MAX STRAHAN, * * Plaintiff, * * v. * Civil Action No. 19-cv-10639-IT * SECRETARY, MASSACHUSETTS * EXECUTIVE OFFICE OF ENERGY AND * AND ENVIRONMENTAL AFFAIRS, * et al., * * Defendants, * * and * * MASSACHUSETTS LOBSTERMEN’S * SURVIVAL FUND, * * Intervenor-Defendant. * * MEMORANDUM AND ORDER June 3, 2021 TALWANI, D.J. Plaintiff Richard Max Strahan’s Amended Complaint [#68] alleges that the Secretary of the Massachusetts Executive Office of Energy and Environmental Affairs and the Director of the Massachusetts Division of Marine Fisheries (collectively, “the Commonwealth Defendants”) have promulgated a regulatory scheme for lobsterpot and gillnet fisheries that violates the federal Endangered Species Act (the “Act”). Specifically, Plaintiff alleges the Commonwealth Defendants are acting in violation of the Act by promulgating regulations that require fishermen in the Commonwealth to deploy gear, such as vertical buoy ropes (VBRs), that harm, capture, or kill endangered whales and sea turtles. Plaintiff requests a declaration that the Commonwealth Defendants have violated the Endangered Species Act and a permanent injunction prohibiting the Commonwealth Defendants from continuing to license the use of VBRs in state waters. The Massachusetts Lobstermen’s Survival Fund (“the Fund”), an unincorporated association of Massachusetts lobstermen, has intervened as a Defendant in this action. A bench trial on Plaintiff’s ESA claim will commence on June 9, 2021.

The Commonwealth Defendants and the Fund have moved, in limine, to exclude, in whole or in part, the testimony of two witnesses disclosed by Plaintiff as witnesses Plaintiff may use at trial to present expert testimony: Dr. Sarah Sharp, and Plaintiff Richard Strahan.1 See Fund Mot. Limine Preclude Dr. Sharp [#400]; Commonwealth’s Mot. Limine Preclude in Part Dr. Sharp [#418]; Commonwealth’s Mot. Limine Exclude Strahan [#415]. For the reasons set forth below, the Fund’s Motion in Limine to Preclude Dr. Sharp [#400] and the Commonwealth’s Motion in Limine to Preclude Dr. Sharp [#418] are DENIED and the Commonwealth Defendants’ Motion in Limine to Preclude Expert Testimony of Strahan [#415] is ALLOWED in part and DENIED in part.

I. LEGAL STANDARD

The admissibility of expert testimony is governed by Federal Rule of Evidence 702, which provides: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if:

1 The Commonwealth and the Fund have also moved, in limine, to exclude the testimony of Plaintiff’s third expert witness, Dr. Michael Moore. See Fund’s Mot. Limine Preclude Dr. Moore [#460]; Commonwealth’s Mot. Limine Preclude Dr. Moore [#462]. Those motions will be addressed in a separate order. (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. Fed. R. Evid. 702. In Daubert v. Merrell Dow Pharms., Inc., the Supreme Court explained that Rule 702 essentially provides three criteria for expert testimony. See 509 U.S. 579, 591 (1993). The first question, a foundational one, is whether the proposed testimony would “assist the trier of fact to understand the evidence or to determine a fact in issue.” Id. at 591 (quoting Fed. R. Evid. 702). As the Supreme Court explained, this “goes primarily to relevance” as “[e]xpert testimony which does not relate to any issue in the case is not relevant and, ergo, non-helpful.” Id. (quoting 3 Weinstein & Berger ¶ 702[02], pp. 702–18). Assuming the proposed testimony would be relevant to a fact in issue, the next step is whether the expert witness is qualified “by knowledge, skill, experience, training, or education.” Id. (quoting Fed. R. Evid. 702). If the expert is so qualified, the court must still ensure that the expert’s reasoning or methodology underlying the testimony is scientifically reliable. Id. at 592–93; see also Fed. R. Evid. 702(b)– (d).2

2 Some courts evaluate these three separate questions in a different order. See, e.g., Gopalratnam v. Hewlett-Packard Co., 877 F.3d 771, 779 (7th Cir. 2017) (“In performing its gatekeeper role under Rule 702 and Daubert, the district court must engage in a three-step analysis before admitting expert testimony. It must determine whether the witness is qualified; whether the expert’s methodology is scientifically reliable; and whether the testimony will assist the trier of fact to understand the evidence or to determine a fact in issue”) (internal quotations omitted). Here, the court starts with whether the testimony will assist the court in understanding the evidence or determining a fact in issue. II. DISCUSSION a. Dr. Sharp The Commonwealth Defendants and the Fund challenge the admissibility of Dr. Sharp’s testimony on all three criteria under Rule 702.3 First, the Fund argues that Dr. Sharp’s testimony is not relevant. Fund Mem. 9–10 [#401]. Second, both the Fund and the Commonwealth

Defendants argue that Dr. Sharp is not qualified to provide testimony on several subsets of topics. Id. at 13–14; State Mem. 2–6 [#418]. Third, the Fund argues that Dr. Sharp’s entire testimony should be excluded since it is unreliable opinion testimony. Fund Mem. 10–13 [#401]. The court addresses the three in turn. i. Relevancy of Testimony The Fund’s first argument is that Dr. Sharp’s proposed testimony is entirely irrelevant. Fund Mem. 9–10 [#401]. Specifically, the Fund argues that Dr. Sharp’s anticipated testimony fails to account for the difference between Canadian and offshore gear versus Massachusetts- licensed coastal lobster gear and that “it is reasonable to assume that Massachusetts coastal

lobster gear is not killing [North Atlantic right whales] because the only confirmed fishing gear found on dead [North Atlantic right whales] have been Canadian.” Id. at 10. The Fund’s argument is properly made through the cross-examination of Dr. Sharp or the proffer of

3 The Fund’s Motion in Limine also argues that Dr. Sharp should be precluded from testifying because she has not submitted an expert report pursuant to Fed. R. Civ. P. 26(a)(2)(B). However, as the court previously ruled with regard to the Fund’s challenge directed to Dr. Moore, “[t]he triggering mechanism for the report requirement is the status of the disclosed witness, as a report is required ‘if the witness is one retained or specially employed to provide expert testimony in the case or one whose duties as the party’s employee regularly involve giving expert testimony.’” Elec. Order [#391] (quoting Fed. R. Civ. P. 26(a)(2)(B)). Because Dr. Sharp, like Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Strahan v. Massachusetts Executive Office of Energy and Environmental Affairs, (D. Mass. 2021).

Strahan v. Massachusetts Executive Office of Energy and Environmental Affairs (Strahan v. Massachusetts Executive Office of Energy and Environmental Affairs) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Alzanki
54 F.3d 994 (First Circuit, 1995)
Nieves-Villanueva v. Soto-Rivera
133 F.3d 92 (First Circuit, 1997)
United States v. Mooney
315 F.3d 54 (First Circuit, 2002)
Levin v. Dalva Brothers, Inc.
459 F.3d 68 (First Circuit, 2006)
United States v. Vargas
471 F.3d 255 (First Circuit, 2006)
Brenda Payton v. Abbott Labs, Eli Lilly and Company
780 F.2d 147 (First Circuit, 1985)
Blanchard v. Eli Lilly & Co.
207 F. Supp. 2d 308 (D. Vermont, 2002)
United States v. Monteiro
407 F. Supp. 2d 351 (D. Massachusetts, 2006)
S. Gopalratnam v. ABC Insurance Company
877 F.3d 771 (Seventh Circuit, 2017)